Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis

被引：23
|
作者：
Mase, G
Zorzon, M
Biasutti, E
Vitrani, B
Cazzato, G
Urban, F
Frezza, M
机构：
[1] UNIV TRIESTE,IST CLIN NEUROL,I-34127 TRIESTE,ITALY
[2] SERV GASTOENTEROL & ENDOSCOPIA DIGEST,VENICE,ITALY
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1996年 / 60卷 / 03期
关键词：
D O I：
10.1136/jnnp.60.3.348-a
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：348 / 349
页数：2
相关论文
共 50 条
  • [21] Development of a myasthenia crisis during interferon treatment for chronic C hepatitis
    Reffet, Armel
    Oddes, Bemord
    Terrier, Francois
    Chaliveau, Eric
    Casassus-Buihle, Didier
    Fraudin, Adrien
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (12): : 1085 - 1087
  • [22] Interferon-alpha treatment for chronic hepatitis C in children
    Yüce, A
    Koçak, N
    Gürakan, F
    Özen, H
    TURKISH JOURNAL OF PEDIATRICS, 2000, 42 (01) : 34 - 38
  • [23] TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA
    ROSS, AG
    BURT, MJ
    JENNINGS, LC
    COLLETT, JA
    WALFORD, EJ
    CHAMBERS, ST
    CHAPMAN, BA
    NEW ZEALAND MEDICAL JOURNAL, 1995, 108 (996) : 101 - 103
  • [24] Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C
    Tada, H
    Saitoh, S
    Nakagawa, Y
    Hirana, H
    Morimoto, M
    Shima, T
    Shimamoto, K
    Okanoue, T
    Kashima, K
    JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) : 582 - 584
  • [25] Response to interferon of anti-HCV positive chronic hepatitis patients: The impact of quantitative HCV-RNA RT-PCR.
    Flichman, D
    Colombatto, P
    Baldi, M
    Negro, F
    Bellati, G
    Randone, A
    Oliveri, F
    Colucci, G
    Bonino, F
    Brunetto, MR
    HEPATOLOGY, 1996, 23 (01) : T20 - T20
  • [26] RESPONSE TO INTERFERON OF ANTI-HCV POSITIVE CHRONIC HEPATITIS PATIENTS - THE IMPACT OF QUANTITATIVE HCV-RNA RT-PCR
    FLICHMAN, D
    COLOMBATTO, AP
    BALDI, M
    NEGRO, F
    BELLATI, G
    RANDONE, A
    OLIVERI, F
    COLUCCI, G
    BONINO, F
    BRUNETTO, MR
    HEPATOLOGY, 1995, 22 (04) : 1239 - 1239
  • [27] THE EFFECT OF ALPHA-2B INTERFERON (IF) TREATMENT ON HCV-RNA, ANTI-HCV ANTIBODIES AND TRANSAMINASES IN PATIENTS WITH CHRONIC HEPATITIS-C
    WILLEMS, M
    NEVENS, F
    MOSHAGE, H
    FEVERY, J
    YAP, SH
    HEPATOLOGY, 1991, 14 (04) : A223 - A223
  • [28] DEVELOPMENT OF GRANULOMATOUS HEPATITIS DURING TREATMENT WITH INTERFERON-ALPHA(2B)
    PROPST, A
    PROPST, T
    DIETZE, O
    KATHREIN, H
    JUDMEIER, G
    VOGEL, W
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (10) : 2117 - 2118
  • [29] HCV RNA IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA
    LIANG, TJ
    RUSTGI, V
    GALUN, E
    BLUM, HE
    JOURNAL OF MEDICAL VIROLOGY, 1993, 40 (01) : 69 - 75
  • [30] Ursodeoxycholic acid with and without interferon-alpha in the treatment of chronic hepatitis
    Podda, M
    Crosignani, A
    Larghi, A
    Invernizzi, P
    Magnani, V
    Zuin, M
    BILE ACIDS AND IMMUNOLOGY, 1996, 86 : 269 - 274
12345